Skip to main content
PolicySpeak
← All files
HF

Healthtech Finland

Industry association · Finland

4
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
4
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track Healthtech in PolicySpeak: request access →

Work at Healthtech Finland? so we know who speaks for it.

Follow the files Healthtech Finland engages with

One email on Tuesdays when a new position is filed on these 3 files, from Healthtech Finland or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Healthtech Finland filed 4 positions between 3 Oct 2025 and 5 Aug 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 4 times.

2025 · 2 filed2026 · 2 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 26 Jun 2026PDFsource

Healthtech Finland thanks the Commission for the possibility to give feedback on the proposal for the amendment of the medical device regulations (MDR and IVDR). The MDR and IVDR change proposal addresses many of the pressing questions and challenges the healthcare sector, healthcare organisations and professionals, as well as the medical device industry, are currently experiencing.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025PDFsource

HealthTech Finland thanks the Commission for opening the Call for Evidence for the medical device regulations (MDR and IVDR). The performance and safety of medical devices (MD) and in vitro diagnostics medical devices (IVD) is crucial to European patients. However, also the availability of devices to patients is a critical part of high-quality care and patient safety.

European Biotech Actfiled 5 Aug 2026PDFsource

Healthtech Finland welcomes the opportunity to provide feedback on the proposal for the Biotech Act (I). Healthtech Finland supports the Act, and its aims to strengthen the EU health biotechnology ecosystem, support innovation, and enhance European competitiveness.

European Innovation Actfiled 3 Oct 2025PDFsource

The European Innovation Act is a timely and necessary initiative to address the fragmentation and inefficiencies that hinder innovation across the EU. However, one critical dimension remains underrepresented in the current framing: regulatory literacy. Regulatory literacy the ability of innovators to understand and navigate regulatory frameworks is foundational to the success of any innovation ecosystem.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 71.

Is this your organization?

Everything on this page comes from Healthtech Finland’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.